Rethinking procurement biopsy in donors with normal renal function: A barrier to kidney utilization without survival benefit

Table 3 Pathology of kidney biopsied and pathology reason for discard, n (%)

Pathology results of biopsy		Non used for biopsy reason
Total biopsies	n = 73776	4371 (5.9)
Combination of lesions
0%-5% GS/absent-mild vascular/absent-mild IFTA	60251 (81.7)	2346 (53.7)
0%-5% GS/moderate-severe IFTA	1979 (2.7)	357 (8.2)
0%-5% GS/moderate-severe vascular	3049 (4.1)	436 (10.0)
0%-5% GS /moderate-severe vascular/moderate-severe IFTA	1320 (1.8)	451 (10.3)
≥ 6% GS/absent-mild vascular/absent-mild IFTA	5771 (7.8)	507 (11.6)
≥ 6% GS /moderate-severe IFTA	360 (0.5)	77 (1.8)
≥ 6% GS /moderate-severe vascular	728 (1.0)	114 (2.6)
≥ 6% GS/moderate-severe vascular/moderate-severe IFTA	318 (0.4)	83 (1.9)

GS: Glomerulosclerosis; IFTA: Interstitial fibrosis/tubular atrophy.